Redox-modulating macrophage biohybrid nanoplatform for targeted RIPK1-PANoptosome suppression in ischemic stroke
Redox Biology · 2026-02 · 89 · 103997
DOI: 10.1016/j.redox.2025.103997 ↗Kurz gefasst
Fachartikel in der Zeitschrift Redox Biology, 2026-02. Verfasst von Wenhui Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Huadong Hospital, Shanghai Key Laboratory of Clinical Geriatric Medicine, Shanghai Institute of Geriatrics and Gerontology, …. Hauptthemen laut MEDLINE: Macrophages, Ischemic Stroke. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission, Science and Technology Innovation Plan Of Shanghai Science and Technology Commission.
Themen: Schlaganfall
Abstract (Originalsprache)
Disruption of redox homeostasis during reperfusion triggers a complex and dynamic neuroinflammatory cascade in ischemic stroke, posing a major barrier to precision therapy. Although cellular therapies have emerged as a promising strategy, their clinical translation is hindered by the lack of tools capable of simultaneously tracking cell delivery and modulating pathological redox imbalance in vivo. Here, we report an MRI-trackable engineered macrophage-derived biohybrid nanoplatform that integrates the inflammation-homing capacity of macrophages, the imaging functionality of ultrasmall superparamagnetic iron oxide nanoparticles, and the redox-regulating activity of 2,2,6,6-tetramethylpiperidine-1-oxyl-doped lipids to restore local redox homeostasis. Leveraging their innate tropism toward inflamed tissue, the engineered macrophages selectively accumulate at sites of post-ischemic neuroinflammation. Concurrently, their intrinsic reactive oxygen species-scavenging capability alleviates oxidative stress, thereby suppressing a redox-dependent network of programmed cell death PANoptosis. In vivo ischemic stroke models demonstrate that this redox-modulating biohybrid nanoplatform significantly inhibits oxidative stress-induced PANoptosis, leading to enhanced neuronal survival and improved neurological recovery. Notably, the engineered macrophages function as both redox state imagers and active modulators, enabling real-time visualization and spatiotemporal regulation of redox dynamics within the ischemic brain. Collectively, this work establishes a precision theranostic strategy to disrupt the oxidative stress-PANoptosis axis and highlights a broadly applicable platform for the treatment of oxidative stress and inflammation associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Huadong Hospital, Shanghai Key Laboratory of Clinical Geriatric Medicine, Shanghai Institute of Geriatrics and Gerontology, State Key Laboratory of Brain Function and Disorders, Fudan University…
- Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, PR China.
- Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, PR China. Electronic address: fengw@shu.edu.cn.
- Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, PR China. Electronic address: chenyuedu@shu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Health Commission
- Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
- Science and Technology Commission of Shanghai Municipality
- National Key Research and Development Program of China
Zitieren
APA
Jiang, W., Xia, C., Cui, Z., Shi, L., Feng, W., Chen, Y., & Zhang, J. (2026). Redox-modulating macrophage biohybrid nanoplatform for targeted RIPK1-PANoptosome suppression in ischemic stroke. Redox Biology, 89, 103997. https://doi.org/10.1016/j.redox.2025.103997
Vancouver
Jiang W, Xia C, Cui Z, Shi L, Feng W, Chen Y, et al. Redox-modulating macrophage biohybrid nanoplatform for targeted RIPK1-PANoptosome suppression in ischemic stroke. Redox Biology. 2026;89:103997. doi:10.1016/j.redox.2025.103997
BibTeX
@article{Jiang2026,
author = {Jiang, Wenhui and Xia, Chundongqiu and Cui, Zhimeng and Shi, Lanhao and Feng, Wei and Chen, Yu and Zhang, Jun},
title = {Redox-modulating macrophage biohybrid nanoplatform for targeted RIPK1-PANoptosome suppression in ischemic stroke},
journal = {Redox Biology},
year = {2026},
volume = {89},
pages = {103997},
doi = {10.1016/j.redox.2025.103997}
}
EUVIMED